• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病亚洲患者心房颤动和卒中的患病率和发病率的时间趋势:一项全国基于人群的研究。

Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study.

机构信息

Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

出版信息

Int J Cardiol. 2018 Dec 15;273:130-135. doi: 10.1016/j.ijcard.2018.08.038. Epub 2018 Aug 11.

DOI:10.1016/j.ijcard.2018.08.038
PMID:30150122
Abstract

BACKGROUND

Atrial fibrillation (AF) and stroke are common in hypertrophic cardiomyopathy (HCM). We aimed to determine the prevalence and incidence of AF and stroke in patients with HCM during a 10-year period.

METHODS

Using the Korean National Health Insurance Services database, we identified patients diagnosed with HCM from the entire Korean population between 2005 and 2015. The annual prevalence and incidence of AF and stroke in HCM patients were estimated.

RESULTS

The prevalence of AF in HCM patients has gradually increased to 1.6-fold from 13.4% in 2005 to 20.9% in 2015. The incidence of AF ranged from 4.1 to 5.5%, a similar trend was observed for each year in HCM patients. The prevalence of stroke in HCM patients was approximately 10%, while that in HCM patients with AF was about 20%. During 8741 person-years, AF-related stroke occurred in 257 subjects among 2309 HCM patients with new-onset AF. The overall incidence rate of AF-associated stroke was 2.94 per 100 person-years. In subgroup analysis, the incidence rate of AF-associated stroke was 1.49 per 100 person-years in the under 45 year-old group and 1.48 per 100 person-years in the group with CHADS-VASc score of 0 or 1 point in HCM patients.

CONCLUSIONS

The prevalence of AF in HCM patients gradually increased over 10 years. The annual risk of AF-associated stroke in HCM was over 1% even in younger patients and those with CHADS-VASc score of 0 or 1 point, which provide evidence to support the prevention of stroke in HCM patients with AF.

摘要

背景

心房颤动(AF)和中风在肥厚型心肌病(HCM)中很常见。我们旨在确定 10 年内 HCM 患者中 AF 和中风的患病率和发生率。

方法

使用韩国国家健康保险服务数据库,我们从 2005 年至 2015 年期间确定了整个韩国人群中诊断为 HCM 的患者。估计了 HCM 患者中 AF 和中风的年患病率和发生率。

结果

HCM 患者中 AF 的患病率从 2005 年的 13.4%逐渐增加到 2015 年的 16.9%,增加了 1.6 倍。AF 的发生率在 HCM 患者中从 4.1%到 5.5%不等,每年的趋势相似。HCM 患者中风的患病率约为 10%,而 AF 合并 HCM 患者的中风患病率约为 20%。在 8741 人年中,在新诊断为 AF 的 2309 例 HCM 患者中,AF 相关的中风发生在 257 例患者中。AF 相关中风的总发生率为每 100 人年 2.94 例。在亚组分析中,在年龄小于 45 岁的 HCM 患者中,AF 相关中风的发生率为每 100 人年 1.49 例,在 CHADS-VASc 评分为 0 或 1 分的 HCM 患者中,AF 相关中风的发生率为每 100 人年 1.48 例。

结论

HCM 患者中 AF 的患病率在 10 年内逐渐增加。即使在年龄较小的患者和 CHADS-VASc 评分为 0 或 1 分的患者中,HCM 患者中 AF 相关中风的年风险也超过 1%,这为预防 AF 合并 HCM 患者的中风提供了证据。

相似文献

1
Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study.肥厚型心肌病亚洲患者心房颤动和卒中的患病率和发病率的时间趋势:一项全国基于人群的研究。
Int J Cardiol. 2018 Dec 15;273:130-135. doi: 10.1016/j.ijcard.2018.08.038. Epub 2018 Aug 11.
2
Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.肥厚型心肌病伴心房颤动患者的卒中风险:全国数据库研究。
Aging (Albany NY). 2020 Nov 23;12(23):24219-24227. doi: 10.18632/aging.104133.
3
Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study.肥厚型心肌病合并心房颤动患者的患病率及卒中风险:一项全国性队列研究。
Thromb Haemost. 2019 Feb;119(2):285-293. doi: 10.1055/s-0038-1676818. Epub 2019 Jan 2.
4
Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHADS-VASc score in the entire Korean population.韩国全体人群中心房颤动的发病率和患病率趋势以及使用CHADS-VASc评分评估的血栓栓塞风险
Int J Cardiol. 2017 Jun 1;236:226-231. doi: 10.1016/j.ijcard.2017.02.039. Epub 2017 Feb 13.
5
Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation.肥厚型心肌病患者中有无心房颤动与缺血性脑卒中的关系。
Stroke. 2022 Feb;53(2):497-504. doi: 10.1161/STROKEAHA.121.034213. Epub 2021 Oct 4.
6
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy: A Nationwide Cohort Study.非维生素 K 拮抗剂口服抗凝剂在伴有肥厚型心肌病的心房颤动患者中的有效性和安全性:一项全国性队列研究。
Chest. 2019 Feb;155(2):354-363. doi: 10.1016/j.chest.2018.11.009. Epub 2018 Nov 22.
7
Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients.肥厚型心肌病患者全国队列中心房颤动的临床影响
Ann Transl Med. 2020 Nov;8(21):1386. doi: 10.21037/atm-20-1817.
8
Risk of ischemic stroke in patients with hypertrophic cardiomyopathy in the absence of atrial fibrillation - a nationwide cohort study.无房颤的肥厚型心肌病患者发生缺血性卒中的风险——一项全国性队列研究
Aging (Albany NY). 2019 Dec 2;11(23):11347-11357. doi: 10.18632/aging.102532.
9
Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study.韩国肥厚型心肌病患病率和发病率的趋势:一项全国基于人群的队列研究。
PLoS One. 2020 Jan 13;15(1):e0227012. doi: 10.1371/journal.pone.0227012. eCollection 2020.
10
Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation.肥厚型心肌病患者即使无房颤病史,也会增加缺血性卒中风险。
Sci Rep. 2022 Sep 22;12(1):15785. doi: 10.1038/s41598-022-19895-x.

引用本文的文献

1
Atrial fibrillation and thromboembolic risk in hypertrophic cardiomyopathy.肥厚型心肌病中的心房颤动与血栓栓塞风险
J Cardiovasc Imaging. 2025 Aug 25;33(1):12. doi: 10.1186/s44348-025-00057-2.
2
Effectiveness of Immediate Pharmacological Versus Electrical Cardioversion on Hemodynamic Stability and Rhythm Restoration in Patients With Refractory Atrial Fibrillation: A Systematic Review.即时药物复律与电复律对难治性心房颤动患者血流动力学稳定性和心律恢复的有效性:一项系统评价
Cureus. 2025 Jun 25;17(6):e86747. doi: 10.7759/cureus.86747. eCollection 2025 Jun.
3
Predictive model development for left atrial remodeling in hypertrophic cardiomyopathy.
肥厚型心肌病左心房重构的预测模型开发
Sci Rep. 2025 Apr 8;15(1):11982. doi: 10.1038/s41598-025-97144-7.
4
Comparison between non-vitamin K oral antagonist versus warfarin in atrial fibrillation with and without valvular heart disease: a systematic review and meta-analysis.非维生素K口服抗凝剂与华法林在伴或不伴有心脏瓣膜病的心房颤动患者中的比较:一项系统评价和荟萃分析。
Egypt Heart J. 2024 Aug 9;76(1):102. doi: 10.1186/s43044-024-00535-w.
5
Association of Fibrate use with clinical expression of hypertrophic cardiomyopathy.贝特类药物的使用与肥厚型心肌病临床表现的关联。
ESC Heart Fail. 2024 Dec;11(6):3972-3981. doi: 10.1002/ehf2.15004. Epub 2024 Jul 25.
6
Cryoablation Utilizing the KODEX-EPD Mapping System Versus Conventional Cryoballoon Ablation in the Management of Patients With Atrial Fibrillation: A Literature Review and Meta-Analysis.使用KODEX-EPD标测系统的冷冻消融与传统冷冻球囊消融治疗心房颤动患者的比较:文献综述与荟萃分析
Cureus. 2024 Apr 30;16(4):e59407. doi: 10.7759/cureus.59407. eCollection 2024 Apr.
7
Pregnancy related complications in women with hypertrophic cardiomyopathy: a nationwide population-based cohort study.妊娠相关并发症在肥厚型心肌病患者中的研究:一项全国基于人群的队列研究。
BMC Cardiovasc Disord. 2024 May 21;24(1):268. doi: 10.1186/s12872-024-03812-3.
8
Temporal trends of hypertrophic cardiomyopathy in Denmark: a nationwide retrospective cohort study.丹麦肥厚型心肌病的时间趋势:一项全国性回顾性队列研究。
BMJ Open. 2023 Sep 4;13(9):e074010. doi: 10.1136/bmjopen-2023-074010.
9
Massive Atrial Thrombosis: A Serious Complication of the Maze Procedure Triggered by Heparin-Induced Thrombocytopenia (HIT).大面积心房血栓形成:肝素诱导的血小板减少症(HIT)引发的迷宫手术严重并发症。
Cureus. 2023 Jul 8;15(7):e41568. doi: 10.7759/cureus.41568. eCollection 2023 Jul.
10
Impact of coronary artery revascularization on long-term outcome in hypertrophic cardiomyopathy patients: a nationwide population-based cohort study.冠状动脉血运重建对肥厚型心肌病患者长期预后的影响:一项全国范围内基于人群的队列研究。
Sci Rep. 2023 Apr 19;13(1):6412. doi: 10.1038/s41598-023-33344-3.